GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Varian Medical Systems Inc (NYSE:VAR) » Definitions » Return-on-Tangible-Equity

Varian Medical Systems (Varian Medical Systems) Return-on-Tangible-Equity : 30.56% (As of Dec. 2020)


View and export this data going back to 1976. Start your Free Trial

What is Varian Medical Systems Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Varian Medical Systems's annualized net income for the quarter that ended in Dec. 2020 was $386 Mil. Varian Medical Systems's average shareholder tangible equity for the quarter that ended in Dec. 2020 was $1,263 Mil. Therefore, Varian Medical Systems's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2020 was 30.56%.

The historical rank and industry rank for Varian Medical Systems's Return-on-Tangible-Equity or its related term are showing as below:

VAR' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 12.42   Med: 28.72   Max: 38.25
Current: 25.25

During the past 13 years, Varian Medical Systems's highest Return-on-Tangible-Equity was 38.25%. The lowest was 12.42%. And the median was 28.72%.

VAR's Return-on-Tangible-Equity is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 1.87 vs VAR: 25.25

Varian Medical Systems Return-on-Tangible-Equity Historical Data

The historical data trend for Varian Medical Systems's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Varian Medical Systems Return-on-Tangible-Equity Chart

Varian Medical Systems Annual Data
Trend Sep11 Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.60 16.43 12.42 28.55 26.45

Varian Medical Systems Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.21 18.11 24.18 27.35 30.56

Competitive Comparison of Varian Medical Systems's Return-on-Tangible-Equity

For the Medical Instruments & Supplies subindustry, Varian Medical Systems's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Varian Medical Systems's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Varian Medical Systems's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Varian Medical Systems's Return-on-Tangible-Equity falls into.



Varian Medical Systems Return-on-Tangible-Equity Calculation

Varian Medical Systems's annualized Return-on-Tangible-Equity for the fiscal year that ended in Sep. 2020 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Sep. 2020 )  (A: Sep. 2019 )(A: Sep. 2020 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Sep. 2020 )  (A: Sep. 2019 )(A: Sep. 2020 )
=269.2/( (855.4+1180.3 )/ 2 )
=269.2/1017.85
=26.45 %

Varian Medical Systems's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2020 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Dec. 2020 )  (Q: Sep. 2020 )(Q: Dec. 2020 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Dec. 2020 )  (Q: Sep. 2020 )(Q: Dec. 2020 )
=386/( (1180.3+1345.6)/ 2 )
=386/1262.95
=30.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2020) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Varian Medical Systems  (NYSE:VAR) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Varian Medical Systems Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Varian Medical Systems's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Varian Medical Systems (Varian Medical Systems) Business Description

Traded in Other Exchanges
N/A
Address
3100 Hansen Way, Palo Alto, CA, USA, 94304-1038
Varian Medical Systems designs, manufactures, and sells radiation technology for use in two business segments: oncology systems and proton therapy. The Americas account for the largest portion of revenue (47%), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (19%).
Executives
Jesse Michael Bruff officer: SVP Finance, CFO 3100 HANSEN WAY, PALO ALTO CA 94304
Magnus Momsen officer: SVP, CAO, Corporate Controller VARIAN MEDICAL SYSTEMS INC. 3100 HANSEN WAY MAIL STOP E327 PALO ALTO CA 94304
Dow R Wilson director, officer: President and CEO VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Kolleen T Kennedy officer: Pres. Proton Solutions, CGO VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Christopher A. Toth officer: SVP and Pres. Oncology Systems 1252 COOLIDGE AVE., SAN JOSE CA 95125
Michael Damon Hutchinson officer: SVP,Chief Legal Officer, Secy 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Jean Luc Butel director ONE BAXTER PARKWAY, DEERFIELD IL 60015
John W Kuo officer: SVP, Gen Counsel and Secretary VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Judy Bruner director C/O SANDISK CORPORATION, 601 MCCARTHY BLVD., MILPITAS CA 95035
Beau Michelle Le director 800 N. MICHIGAN AVENUE #3703 CHICAGO IL 60611
Anat Ashkenazi director LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Jeffrey R. Balser director 3657 RICHLAND AVE., NASHVILLE TN 37205
Regina E Dugan director VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
David J Illingworth director 3100 HANSEN WAY PALO ALTO CA 94304
R Andrew Eckert director THREE RAVINIA DRIVE, ATLANTA GA 30346

Varian Medical Systems (Varian Medical Systems) Headlines

From GuruFocus

Varian Announces CEO Succession Plan

By PRNewswire PRNewswire 03-02-2021